Just Eat Takeaway raises 2023 guidance, launches buyback
..
Headlines
Headlines
..
Headlines
..
Headlines
..
Headlines
..
Headlines
..
Headlines
..
Headlines
Investors are particularly interested in GSK’s future plans, given the pending loss of patent protection in 2027 for dolutegrav..
Headlines
..
Headlines
..
Headlines
..
Headlines